Endocrinology Pediatrics Oncology  

Key Publication Snapshot 2 – Identifying patients with NTRK fusion cancer

Prof. Fernando López-Ríos

Prof. Fernando López-Ríos
Publication Date

Sep 2021

info Summary and next episodes download Downloadable resources

Prof. Fernando López-Ríos (NTRK CONNECT) has developed this resource with COR2ED.

Fernando Lopez-Rios is the Chief of the Molecular Diagnostics Service at Hospital Universitario 12 de Octubre (Madrid) and Professor of Pathology at Universidad Complutense (Madrid).

 

Dr Lopez-Rios has also been the Director of the Therapeutic Targets Laboratory at HM Hospitales (Spain) and a visiting researcher at Memorial Sloan Kettering Cancer Center (New York).

 

He is the 2023 recipient of the Mary J. Matthews Pathology & Transitional Research Award (International Association for the Study of Lung Cancer, IASLC) and the Deputy Chair of the IASLC Pathology Committee.

 

His main clinical and research expertise is in cancer biomarker testing.

Prof. Fernando López-Ríos has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Honoraria:  AbbVie, AstraZeneca, Bayer, BMS, Boehringer Ingelheim, Daiichi Sankyo, Janssen, Lilly, MSD, Pfizer, Regeneron, Roche, and Thermo Fisher. 

Research support: AstraZeneca, Janssen, Lilly, Pfizer, Roche, and Thermo Fisher.   
Programme summary
  • clock Duration 5 MIN
  • clock Downloadable resources Yes
  • pdf PPTX FILE
  • clock Language(s) flag
Watch the video now
Share this programme
x-twitter
This educational programme is supported by an Independent Educational Grant from Bayer
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from Bayer
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
PRECISION ONCOLOGY CONNECT

PRECISION ONCOLOGY CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from AstraZeneca, Amoy Diagnostics, Bayer, Pierre Fabre Laboratories, Thermo Fisher Scientific and Daiichi Sankyo.

Meet the experts Independent IME approved

Other programmes of interest

conference-update Conference update
Oncology 
Highlights from ESMO 2026

Experts join us at ESMO 2026 to share their insights on new data on GI, liver, lung, breast and GU cancers

Experts
Dr Elizabeth Smyth, Dr Yelena Janjigian, Assoc. Prof. Gerald Prager, Prof. Hong Jae Chon, Assoc. Prof. Lorenza Rimassa, Dr Tom Newsom-Davis, Dr Louise Lim, Dr Komal Jhaveri, Dr Roberto Iacovelli
Endorsed by
ICAN international cancer advocacy network Biomarker Collaborative Exon20group
MET crusaders
  • clock 3 MIN
  • calendar Oct 2026
  • Non-accredited Independent Medical Education
COR2ED GI NURSES CONNECT PRECISION ONCOLOGY CONNECT GU NURSES CONNECT GI CONNECT
podcast Video podcast
Oncology 
Metastatic TNBC cannot wait

Optimising 1st line TROP2 ADC decisions in metastatic triple-negative breast cancer

Experts
Prof. Giuseppe Curigliano, Prof. Javier Cortés
  • download Downloadable
    Resources
  • clock 27 MIN
  • calendar Oct 2026
  • Non-accredited Independent Medical Education
BREAST CANCER CONNECT
Educational programme supported by an Independent Educational Grant from AstraZeneca.
Explore all programmes